Daily Sepsis Research Analysis
Three studies reshape neonatal and early-infant sepsis thinking. Metagenomic evidence shows the infant gut often harbors the exact strain that later causes invasive infection. Large prospective NICU data link indwelling devices and first-week antibiotic exposure to higher healthcare-associated BSI risk, while a pharmacist-led stewardship program safely halved early-onset sepsis antibiotic use and reduced multidrug-resistant organisms.
Summary
Three studies reshape neonatal and early-infant sepsis thinking. Metagenomic evidence shows the infant gut often harbors the exact strain that later causes invasive infection. Large prospective NICU data link indwelling devices and first-week antibiotic exposure to higher healthcare-associated BSI risk, while a pharmacist-led stewardship program safely halved early-onset sepsis antibiotic use and reduced multidrug-resistant organisms.
Research Themes
- Microbiome reservoirs and invasive infections in infants
- Antimicrobial stewardship in neonatal sepsis
- Device-associated risk factors for NICU bloodstream infections
Selected Articles
1. Metagenomic signatures of extraintestinal bacterial infection in the febrile term infant gut microbiome.
In febrile term infants, 63% of extraintestinal infections had an intestinal strain essentially identical to the invasive pathogen (>99.999% ANI), supporting the gut as a reservoir. E. coli cases showed higher gut E. coli abundance, enrichment of phylogroup B2, and virulence loci in isogenic colonized infants.
Impact: This study mechanistically links the infant gut to subsequent invasive infection with strain-level resolution, opening avenues for pre-symptomatic surveillance and prevention.
Clinical Implications: Consider targeted surveillance/decolonization among colonized infants (e.g., high-risk E. coli B2 carriers) and refine risk stratification beyond clinical signs by incorporating gut microbiome signatures.
Key Findings
- In 63% of EBI cases, a gut strain was presumptively isogenic to the invasive pathogen (>99.999% ANI).
- E. coli EBIs were associated with increased gut E. coli relative abundance versus controls.
- Isogenic E. coli colonization correlated with higher phylogroup B2 abundance and enrichment of virulence factor loci.
Methodological Strengths
- Strain-level integration of fecal metagenomics with invasive-site isolate genomics using stringent ANI thresholds.
- Multicenter design across 13 emergency departments with matched febrile controls.
Limitations
- Moderate sample size and observational design limit causal inference.
- Single-country ED network; timing between stool sampling and infection onset may affect detectability.
Future Directions: Prospective interventional studies testing surveillance, decolonization, or microbiome-modulating strategies in colonized infants; validation in diverse populations and preterm cohorts.
BACKGROUND: Extraintestinal bacterial infections (EBIs), e.g., urinary tract infection, bacteremia, and meningitis, occur in approximately 10% of febrile infants younger than 60 days. Although many EBI-causing species commonly reside in the infant gut, proof that the digestive system is a pre-infection habitat remains unestablished. RESULTS: We studied a cohort of febrile term infants < 60 days old who presented to one of thirteen US emergency departments in the Pediatric Emergency Care Applied Research Network from 2016 to 2019. Forty EBI cases and 74 febrile controls matched for age, sex, and race without documented EBIs were selected for analysis. Shotgun sequencing was performed of the gut microbiome and of strains cultured from the gut and extraintestinal site(s) of EBI cases, including blood, urine, and/or cerebrospinal fluid. Using a combination of EBI isolate genomics and fecal metagenomics, we detected an intestinal strain presumptively isogenic to the EBI pathogen (> 99.999% average nucleotide identity) in 63% of infants with EBIs. Although there was no difference in gut microbiome diversity between cases and controls, we observed significantly increased Escherichia coli relative abundance in the gut microbiome of infants with EBIs caused by E. coli. Infants with E. coli infections who were colonized by the putatively isogenic pathogen strain had significantly higher E. coli phylogroup B2 abundance in their gut, and their microbiome was more likely to contain virulence factor loci associated with adherence, exotoxin production, and nutritional/metabolic function. CONCLUSIONS: The intestine plausibly serves as a reservoir for EBI pathogens in a subset of febrile term infants, prompting consideration of new opportunities for surveillance and EBI prevention among colonized, pre-symptomatic infants. Video Abstract.
2. Risk Factors for Health Care-Associated Bloodstream Infections in NICUs.
Across 6410 NICU admissions, device use in the preceding 3 days and first-week antibiotic exposure were major risk factors for healthcare-associated BSI. Gram-negative organisms predominated with high cephalosporin and carbapenem resistance, underscoring prevention and stewardship priorities.
Impact: Identifies modifiable, high-yield prevention targets (indwelling devices and early antibiotic exposure) using large prospective data in a resource-limited setting.
Clinical Implications: Prioritize device bundles, minimize catheter dwell time, and limit empiric antibiotic exposure in the first week when safe; integrate stewardship with infection prevention.
Key Findings
- Healthcare-associated BSI incidence: 6.09 per 1000 patient-days among 6410 neonates.
- Gram-negative organisms predominated; 85.5% resistant to 3rd/4th-gen cephalosporins and 44.8% to carbapenems.
- Central venous catheters, respiratory support, and urinary catheters increased hazard; first-week antibiotics raised BSI risk nearly threefold (aHR 2.82).
Methodological Strengths
- Multicenter prospective cohort with large sample size and time-updated risk assessment.
- Robust hazard modeling and stratified analysis for first-week antibiotic exposure.
Limitations
- Generalizability may be limited to similar NICU settings; residual confounding cannot be excluded.
- BSI defined by culture positivity from day 3 onward may miss culture-negative infections.
Future Directions: Cluster-randomized trials of device bundle optimization and early antibiotic stewardship pathways; implementation science to adapt strategies in diverse LMIC NICUs.
IMPORTANCE: Neonates requiring intensive care are at high risk of health care-associated infections. In neonatal intensive care units (NICUs) in low-resource settings, the identification of modifiable risk factors can inform targeted prevention strategies to reduce the global burden of neonatal morbidity and mortality. OBJECTIVE: To describe the incidence of and the risk factors associated with health care-associated bloodstream infections (BSIs) in NICUs in Pune, India. DESIGN, SETTING, AND PARTICIPANTS: This multicenter prospective cohort study enrolled all neonates admitted to 3 NICUs in Pune, India, from May 1, 2017, to July 31, 2019. Neonates were followed up from admission until discharge, transfer, or death. This secondary data analysis included neonates admitted for 3 days or more and was completed on January 31, 2024. MAIN OUTCOMES AND MEASURES: The primary outcome was health care-associated BSIs, defined as a positive blood culture on or after admission day 3. Summary statistics, incidence of health care-associated BSIs, and hazard rate by characteristics of interest were generated. Among neonates admitted for 7 days or longer, the association between antibiotic exposure and infection risk was assessed. RESULTS: A total of 6410 neonates were admitted for 3 days or longer. The median gestational age was 34 weeks (IQR, 32-37 weeks), and 3560 (55.5%) were male. The incidence of health care-associated BSIs was 6.09 per 1000 patient-days. Most isolates were gram-negative organisms (n = 273 [66.3%]), of which 85.5% (202 of 236 isolates tested) were resistant to third- or fourth-generation cephalosporins and 44.8% (117 of 261 isolates tested) were resistant to carbapenems. The hazard rate of health care-associated BSIs was higher among neonates with central venous catheters, respiratory support, or urinary catheters within 3 days preceding infection. Of 3229 neonates admitted for 7 days or longer, 190 (5.8%) had health care-associated BSIs on or after hospital day 7, with an incidence of 3.22 per 1000 patient-days. Antibiotic exposure during the first week of admission was associated with a nearly 3-fold increase in the risk of health care-associated BSIs (adjusted hazard ratio, 2.82 [95% CI, 1.26-6.32]). CONCLUSIONS AND RELEVANCE: In this cohort study of 6410 neonates admitted to 3 NICUs in Pune, India, the risk of health care-associated BSIs was associated with the presence of indwelling devices and prior antibiotic exposure. Future efforts should focus on mitigating the risks associated with indwelling devices and strengthening infection prevention and control and antimicrobial stewardship programs to prevent health care-associated infections.
3. Interventions by Clinical Pharmacists Reduced Unnecessary Antibiotics Exposure for Early-Onset Sepsis in a Neonatology Department.
A pharmacist-led, phased EOS protocol cut antibiotic utilization from 58.1% to 31.7% and reduced MDR organism cultures without compromising safety across nearly 10,000 neonates.
Impact: Demonstrates a scalable stewardship model that meaningfully reduces antibiotic exposure and multidrug resistance in early-onset sepsis without safety trade-offs.
Clinical Implications: Implement pharmacist-led EOS stewardship with explicit criteria for withholding antibiotics in low-risk scenarios to curb resistance while maintaining safety.
Key Findings
- Antibiotic use rate decreased from 58.1% (pre-AMS) to 51.9% (phase 1) and 31.7% (phase 2), p<0.0001.
- Days of therapy per 100 patient-days declined (30.8 to 28.3 to 24.8), p<0.0001.
- Multidrug-resistant organism culture rate fell from 48.2% to 37.0% across phases, p<0.01, with no deterioration in safety outcomes.
Methodological Strengths
- Very large sample size with phased protocol implementation enabling dose–response assessment.
- Real-world stewardship led by pharmacists with clear operational criteria.
Limitations
- Retrospective, single-department before–after design susceptible to secular trends and confounding.
- Lack of randomization and limited detail on case-mix changes over time.
Future Directions: Prospective, multicenter implementation trials to validate safety and effectiveness, with cost-effectiveness analyses and long-term resistance surveillance.
AIM: To observe the effect of pharmacist-led antimicrobial stewardship (AMS) on antibiotic exposure for infants with suspected early-onset sepsis (EOS). METHODS: A retrospective observational study was performed. The pharmacist was responsible for the development, education, and supervision of the implementation of the local EOS management protocol. In phase 1, the protocol was established completely according to the latest domestic consensus. In phase 2, the protocol was updated and defined which steps should be taken for specific risk factors and situations in which antibiotics were not necessary down to the detail. RESULTS: A total of 9880 neonates were enrolled. The antibiotic use rate decreased from 58.1% before AMS was implemented to 51.9% in phase 1, and further to 31.7% in phase 2 (p < 0.0001). Days of therapy per 100 patient days were 30.8, 28.3, and 24.8, respectively (p < 0.0001). Multidrug-resistant organism culture rate gradually decreased from 48.2% to 45.5% in phase 1, and further to 37.0% in phase 2 (p < 0.01). No difference in safety outcomes was observed between the intervention and baseline periods. CONCLUSION: A practical AMS led by a pharmacist can safely and successfully reduce the prescription rate of antibiotics for EOS and the incidence of multidrug-resistant bacteria.